These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19292941)

  • 1. A preliminary investigation of the association between serum uric acid and impaired renal function.
    Chen YC; Su CT; Wang ST; Lee HD; Lin SY
    Chang Gung Med J; 2009; 32(1):66-71. PubMed ID: 19292941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers.
    Alasia DD; Emem-Chioma PC; Wokoma FS
    Int J Occup Environ Med; 2010 Oct; 1(4):182-90. PubMed ID: 23022807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and renal function in multiple sclerosis.
    Kanabrocki EL; Ryan MD; Hermida RC; Ayala DE; McCormick JB; Dawson S; Lojo L; Hoffman HS; Siegel G; Friedman N; Eladasori B; Parachuri R; Nemchausky BA
    Clin Ter; 2008; 159(1):35-40. PubMed ID: 18399261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of aging on renal function test].
    Yoshida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Dec; 46(12):1311-4. PubMed ID: 7852769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazinamide induced hyperuricemia in patients taking anti-tuberculous therapy.
    Solangi GA; Zuberi BF; Shaikh S; Shaikh WM
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):136-8. PubMed ID: 15228843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
    Fujimori S; Ooyama K; Ooyama H; Moromizato H
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1035-8. PubMed ID: 22132953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum markers of chronic dehydration are associated with saliva spinability.
    Yoshihara A; Hirotomi T; Takano N; Kondo T; Hanada N; Miyazaki H
    J Oral Rehabil; 2007 Oct; 34(10):733-8. PubMed ID: 17824885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum uric acid level and coronary blood flow.
    Yildiz A; Yilmaz R; Demirbag R; Gur M; Bas MM; Erel O
    Coron Artery Dis; 2007 Dec; 18(8):607-13. PubMed ID: 18004110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperuricemia as a marker for anaerobic threshold in chronic cardiac failure].
    Martínez A; Pérez P; Ossa C; Corbalán R; Jalil J; Castro P; Acevedo M
    Rev Med Chil; 2001 May; 129(5):503-8. PubMed ID: 11464531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
    Biniaz V; Tayebi A; Ebadi A; Sadeghi Shermeh M; Einollahi B
    Iran J Kidney Dis; 2014 Sep; 8(5):401-7. PubMed ID: 25194408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of patients with hyperuricemia.
    Akkasilpa S; Avihingsanon Y; Hanvivadhanakul P; Wonchinsri J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S41-4. PubMed ID: 16083159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Falqui V; Parodi A; Conti N; Derchi LE; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2007 Dec; 20(12):1276-82. PubMed ID: 18047917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid: a risk factor and a target for treatment?
    Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.